Related references
Note: Only part of the references are listed.Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Eolia Brissot et al.
BULLETIN DU CANCER (2020)
Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Aibin Zhang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation
Koji Nishikawa et al.
BONE MARROW TRANSPLANTATION (2020)
Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib
Alexandre E. Malek et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center
Bruno Fernando Buzo et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive Donors
Yibo Wu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Anne Conrad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country
Ahmet Murt et al.
ANNALS OF HEMATOLOGY (2020)
Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients
Krittiya Chaichotjinda et al.
CLINICAL TRANSPLANTATION (2020)
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
Jessica P. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection
Chunmei Yang et al.
LEUKEMIA (2020)
Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV
Wai-Kay Seto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab
Emanuela Zappulo et al.
INFECTION (2019)
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
Jia-Hau Liu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis
Idanna Innocenti et al.
LEUKEMIA & LYMPHOMA (2019)
Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection
Paolo Strati et al.
BLOOD (2019)
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
Hae Lim Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2019)
A global scientific strategy to cure hepatitis B
Peter A. Revill et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
Ivana Lazarevic et al.
VIRUSES-BASEL (2019)
HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
Giuseppe Gentile et al.
VIRUSES-BASEL (2019)
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma
Jia Wei et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Shigeru Kusumoto et al.
BLOOD (2019)
HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center
Sung Kwan Bae et al.
BONE MARROW TRANSPLANTATION (2019)
Risk of hepatitis B virus reactivation in patients treated with ibrutinib
Sarah P. Hammond et al.
BLOOD (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Hepatitis B virus infection
Man-Fung Yuen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection
Tadashi Inuzuka et al.
SCIENTIFIC REPORTS (2018)
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Anil Arora et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review
Evangelos Cholongitas et al.
ANNALS OF GASTROENTEROLOGY (2018)
Hepatitis B Reactivation in Occult Viral Carriers Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Study
Wai-Kay Seto et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper
L. Sarmati et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal
C. Cerva et al.
BMC INFECTIOUS DISEASES (2017)
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Fuqiang Cui et al.
EMERGING INFECTIOUS DISEASES (2017)
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Ankur Varma et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors
M. Lindemann et al.
BONE MARROW TRANSPLANTATION (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
Yuri Cho et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center
S. K. Bae et al.
BONE MARROW TRANSPLANTATION (2016)
A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience
J. Shang et al.
BONE MARROW TRANSPLANTATION (2016)
Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy
Stevan A. Gonzalez et al.
CLINICAL INFECTIOUS DISEASES (2016)
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
C. Cerva et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
Vincent Mallet et al.
LANCET INFECTIOUS DISEASES (2016)
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy
Man Fai Law et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Prevention of Hepatitis B reactivation in the setting of immunosuppression
Venessa Pattullo
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
Shigeru Kusumoto et al.
CLINICAL INFECTIOUS DISEASES (2015)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Robert P. Perrillo et al.
GASTROENTEROLOGY (2015)
Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?
Adrian M. Di Bisceglie et al.
HEPATOLOGY (2015)
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
Jessica P. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients
Ya-Ping Liao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
Maurizio Pompili et al.
ANNALS OF HEPATOLOGY (2015)
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome
M. Mikulska et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
Chiun Hsu et al.
HEPATOLOGY (2014)
Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment
Shingo Nakamoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
Wai-Kay Seto et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection
M. Takahata et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation
Jun Aoki et al.
SPRINGERPLUS (2014)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Yi-Hsiang Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
Sung-Nan Pei et al.
ANNALS OF HEMATOLOGY (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy
Jessica P. Hwang et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Entecavir Is Safe and Effective As Prophylaxis for Reactivation of Hepatitis B Virus in Allogeneic Stem Cell Transplant Recipients with Chronic or Resolved Viral Hepatitis B Infection
Masanori Tsuji et al.
BLOOD (2012)
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
M. Vigano et al.
BONE MARROW TRANSPLANTATION (2011)
Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B
L-T Chiang et al.
INFECTION (2011)
The difficulties of managing severe hepatitis B virus reactivation
Bruno Roche et al.
LIVER INTERNATIONAL (2011)
Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation
Sarah P. Hammond et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
Chiun Hsu et al.
HEPATOLOGY (2008)
Effectiveness of prophylactic anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors
CK Hui et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area
CK Hui et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation
A Locasciulli et al.
BONE MARROW TRANSPLANTATION (2003)
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
GKK Lau et al.
GASTROENTEROLOGY (2003)
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation
GKK Lau et al.
HEPATOLOGY (2002)
Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation
PM Chen et al.
TRANSPLANTATION (2002)
Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes
K Kakimi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease
RP Perrillo
GASTROENTEROLOGY (2001)
Share Paper
